cui,en,en_id
C1423633,TLR9,en_135
C0001047,Acetylcysteine,en_219
C0001962,Ethanol,en_271
C0004057,Aspirin,en_414
C0005767,Blood,en_482
C0006906,Capillary Permeability,en_551
C0010592,Cyclosporine,en_740
C0012582,Dipyridamole,en_823
C0014520,Epidermis,en_916
C0019134,Heparin,en_1166
C0020336,Hydroxychloroquine,en_1226
C0020962,Immune system,en_1271
C0025815,Methylprednisolone,en_1559
C0029235,Organism,en_1717
C0032857,Povidone-Iodine,en_1864
C0034997,Rehydration,en_1990
C0040018,Thrombin,en_2228
C0042395,Vasoactive Intestinal Peptide,en_2339
C0063700,Interferon Regulatory Factor 1,en_2508
C0108768,CD14 Antigen,en_2758
C0111318,Curosurf,en_2761
C0162337,Vascular Permeability,en_2906
C0216231,sargramostim,en_3191
C0216784,valsartan,en_3193
C0221923,Stratum granulosum,en_3231
C0232374,Increased blood vessel permeability,en_3278
C0439663,Infected,en_4036
C0439861,Substance,en_4040
C0587279,Methylprednisolone pulse therapy,en_4362
C0699251,Fluimucil,en_4700
C0699605,Neoral,en_4701
C0701500,Leukine,en_4732
C0723739,Thrombogen,en_4749
C0732282,Aggrenox,en_4771
C0762640,thymic stromal lymphopoietin,en_4865
C0771648,Poractant alfa,en_4873
C0907850,ciclesonide,en_5095
C0948008,Ischemic stroke,en_5158
C0963057,Toll-like receptor 9,en_5199
C1148561,anticoagulant activity,en_5297
C1174745,Alvesco,en_5380
C1333258,DUSP3 gene,en_5589
C1333317,Dual Specificity Phosphatase 3,en_5590
C1336681,TSLP gene,en_5638
C1366516,IRF1 gene,en_5659
C1366646,VIP gene,en_5668
C1367477,CD14 gene,en_5672
C1518997,Peripheral Blood Lymphocyte,en_5878
C1609165,tocilizumab,en_6003
C2733531,Low molecular weight heparin therapy,en_6131
C2917212,Negative Regulation of Coagulation,en_6142
C3152857,Prevail,en_6174
C4033616,Entresto,en_6297
C4085194,Conventional Dendritic Cell,en_6318
C4330475,Immune Cell,en_6345
C4510396,Tocilizumab therapy,en_6356
C5190549,Hydroxychloroquine therapy,en_6409
C5392833,Acute Ischemic Stroke,en_6450
